Why in news? India’s first indigenous mRNA vaccine for the Omicron variant, GEMCOVAC-OM has been approved under ...

Why in news? Bharat Biotech International Limited announced that iNCOVACC, has received approval from the Drugs Co...

Why in news? The Pune-based Gennova Biopharmaceuticals is expected to roll out India’s first home-grown mRNA...

Why in news? India gave emergency-use authorisation to two more vaccines- Corbevax and Covovax. About Corbeva...

Why in news? Researchers have developed an experimental chewing gum that traps SARS-CoV-2 viral particles, the cor...

Why in news? An expert panel of India's Central Drug Authority, which recently reviewed Serum Institute's ...

Why in news? The World Health Organisation (WHO) designated SARS-CoV-2 variant B.1.1529 (named as Omicron) as a &l...

Why in news India’s first indigenous COVID-19 vaccine, Bharat Biotech’s Covaxin, was granted Emergency...

Why in news? The decline in daily new infections across India has prompted INSACOG, the consortium of labs focusse...

Why in news? Prime minister’s Citizen Assistance and Relief in Emergency Situation Fund (PM-CARES Fund), a chari...